CalciMedica Stock (NASDAQ: CALC) stock price, news, charts, stock research, profile.
Open | $5.500 |
Close | $5.450 |
Volume / Avg. | 8.939K / 22.948K |
Day Range | 5.330 - 5.580 |
52 Wk Range | 1.750 - 8.590 |
Market Cap | $48.331M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 0.5% |
Days to Cover | 2.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CalciMedica (NASDAQ: CALC) through any online brokerage.
Other companies in CalciMedica’s space includes: SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX), Ocuphire Pharma (NASDAQ:OCUP), Marinus Pharma (NASDAQ:MRNS) and Cara Therapeutics (NASDAQ:CARA).
The latest price target for CalciMedica (NASDAQ: CALC) was reported by Oppenheimer on Monday, April 1, 2024. The analyst firm set a price target for 14.00 expecting CALC to rise to within 12 months (a possible 211.11% upside). 10 analyst firms have reported ratings in the last year.
The stock price for CalciMedica (NASDAQ: CALC) is $4.5 last updated April 24, 2024 at 8:00 AM EDT.
There are no upcoming dividends for CalciMedica.
CalciMedica’s Q1 earnings are confirmed for Tuesday, May 28, 2024.
There is no upcoming split for CalciMedica.
CalciMedica is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.